Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spero Therapeutics (SPRO) Current Taxes (2023 - 2025)

Spero Therapeutics' Current Taxes history spans 3 years, with the latest figure at $383000.0 for Q4 2025.

  • For Q4 2025, Current Taxes rose 120.11% year-over-year to $383000.0; the TTM value through Dec 2025 reached $383000.0, up 120.11%, while the annual FY2025 figure was $383000.0, 120.11% up from the prior year.
  • Current Taxes reached $383000.0 in Q4 2025 per SPRO's latest filing, up from $163000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $2.2 million in Q3 2023 to a low of $97000.0 in Q3 2024.
  • Average Current Taxes over 3 years is $452600.0, with a median of $278500.0 recorded in 2024.
  • Peak YoY movement for Current Taxes: crashed 95.61% in 2024, then soared 120.11% in 2025.
  • A 3-year view of Current Taxes shows it stood at $387000.0 in 2023, then plummeted by 55.04% to $174000.0 in 2024, then skyrocketed by 120.11% to $383000.0 in 2025.
  • Per Business Quant, the three most recent readings for SPRO's Current Taxes are $383000.0 (Q4 2025), $163000.0 (Q3 2025), and $163000.0 (Q2 2025).